AJP - Endocrinology and Metabolism, Vol 270, Issue 3 E463-E470, Copyright © 1996 by American Physiological Society

ARTICLES

Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM

L. J. Mandarino, A. Consoli, A. Jain and D. E. Kelley
Division of Diabetes, Department of Medicine, The University of Texas Health Science Center at San Antonio 78284-7886, USA.

The current study was undertaken to examine the impact that obesity and non-insulin-dependent diabetes mellitus (NIDDM) have on the ability of glucose to stimulate its own uptake and oxidation in muscle. Euglycemic and hyperglycemic clamp experiments were performed with somatostatin infusions so that insulin could be replaced to basal levels or to physiological hyperinsulinemia. Arteriovenous leg balance methods were used to measure the pathways of leg muscle glucose uptake, oxidation, and storage. Percutaneous biopsies of the vastus lateralis muscle were taken to determine the pyruvate dehydrogenase complex or glycogen synthase activities. During basal insulin replacement, obese compared with lean nondiabetic subjects had higher values for glucose uptake, respiratory quotient, and glucose oxidation (all P<0.05) and a higher proportion of leg energy expenditure derived from glucose. Obese NIDD patients had a greater reliance on fat calories than lean diabetics during basal insulin replacement (P< 0.05). Hyperinsulinemia increased leg glucose metabolism (P<0.001) in all groups, but obese NIDD patients were significantly more insulin resistant. Hyperglycemia in NIDDM compensated for insulin resistance to the extent that rates of glucose metabolism were the same as those for nondiabetics studied at euglycemia. When nondiabetics were studied at hyperglycemia matched to the diabetics, the insulin resistance was still readily apparent.

This article has been cited by other articles:

				J. Koska, E. Ortega, C. Bogardus, J. Krakoff, and J. C. Bunt The effect of insulin on net lipid oxidation predicts worsening of insulin resistance and development of type 2 diabetes mellitus Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E264 - E269. [Abstract] [Full Text] [PDF]

				P. S. MacLean, J. A. Higgins, G. C. Johnson, B. K. Fleming-Elder, J. C. Peters, and J. O. Hill Metabolic adjustments with the development, treatment, and recurrence of obesity in obesity-prone rats Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R288 - R297. [Abstract] [Full Text] [PDF]

				K. Hojlund, K. J. Mustard, P. Staehr, D. G. Hardie, H. Beck-Nielsen, E. A. Richter, and J. F. P. Wojtaszewski AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes Am J Physiol Endocrinol Metab, February 1, 2004; 286(2): E239 - E244. [Abstract] [Full Text] [PDF]

				T. Pratipanawatr, K. Cusi, P. Ngo, W. Pratipanawatr, L. J. Mandarino, and R. A. DeFronzo Normalization of Plasma Glucose Concentration by Insulin Therapy Improves Insulin-Stimulated Glycogen Synthesis in Type 2 Diabetes Diabetes, February 1, 2002; 51(2): 462 - 468. [Abstract] [Full Text] [PDF]

				D. E. Kelley, B. Goodpaster, R. R. Wing, and J.-A. Simoneau Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss Am J Physiol Endocrinol Metab, December 1, 1999; 277(6): E1130 - E1141. [Abstract] [Full Text] [PDF]

				N. B. Ruderman, A. K. Saha, D. Vavvas, and L. A. Witters Malonyl-CoA, fuel sensing, and insulin resistance Am J Physiol Endocrinol Metab, January 1, 1999; 276(1): E1 - E18. [Abstract] [Full Text] [PDF]